Vincenzo Verdi

Dr. Vincenzo Verdi

orcid
Postdoctoral Fellow at NIH/NCI

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

12 December 2016 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
Valentina Di LibertoValentina Di Liberto
Valentina Di Liberto
MFMonica Frinchi
Monica Frinchi
Vincenzo VerdiVincenzo Verdi
Vincenzo Verdi
AVAngela Vitale
Angela Vitale
Fulvio PlesciaFulvio Plescia
Fulvio Plescia
Giuseppa MudòGiuseppa Mudò
Giuseppa Mudò

4 July 2025 in Advanced Healthcare Materials
Verified
Journal Article
Open access
PCPol Escudé Martinez de Castilla
Pol Escudé Martinez de Castilla
Vincenzo VerdiVincenzo Verdi
Vincenzo Verdi
WVWillemijn de Voogt
Willemijn de Voogt
MSMariona Estapé Sentí
Mariona Estapé Sentí
AKArnold C. Koekman
Arnold C. Koekman
RSRaymond Schiffelers
Raymond Schiffelers
Prostate cancer (PCa) ranks as the fifth leading cause of cancer‐related deaths among men worldwide. In 10–20% of the cases, PCa progresses to an incurable, castration‐resistant stage. Castration‐resistant PCa cells often overexpress prostate‐specific membrane antigen (PSMA), a membrane protein that may serve as their Achilles' heel. Over the past decades, RNA‐based therapeutics have emerged as promising treatments for a vast array of diseases, including cancer. In this study, with the ultimate goal of developing a targeted therapy for PCa, lipid nanoparticles (LNPs) are decorated with an anti‐PSMA nanobody using click chemistry with a PEG‐lipid. Direct stochastic optical reconstruction microscopy (dSTORM) and cluster analysis confirm the presence of at least one nanobody on the surface of 80% of LNPs. These anti‐PSMA LNPs exhibit enhanced and specific uptake, and mRNA transfection in PSMA+ cancer cells both in vitro and in a Zebrafish (ZF) metastatic PCa xenograft model. Additionally, in a mouse PSMA‐positive xenograft model, systemic administration results in increased LNP accumulation, but not functional mRNA delivery. These findings underscore both the potential and the challenges of using a PSMA‐targeted lipid nanoparticle system for mRNA delivery into advanced prostate cancer tumors.

Verified
Journal Article
Open access
PDF file
MFMonica Frinchi
Monica Frinchi
Vincenzo VerdiVincenzo Verdi
Vincenzo Verdi
Fulvio PlesciaFulvio Plescia
Fulvio Plescia
FRANCISCO CIRUELAFRANCISCO CIRUELA
FRANCISCO CIRUELA
MGMaria Grillo
Maria Grillo
Giuseppa MudòGiuseppa Mudò
Giuseppa Mudò
Acute or chronic administration of guanosine (GUO) induces anxiolytic-like effects, for which the adenosine (ADO) system involvement has been postulated yet without a direct experimental evidence. Thus, we aimed to investigate whether adenosine receptors (ARs) are involved in the GUO-mediated anxiolytic-like effect, evaluated by three anxiety-related paradigms in rats. First, we confirmed that acute treatment with GUO exerts an anxiolytic-like effect. Subsequently, we investigated the effects of pretreatment with ADO or A1R (CPA, CCPA) or A2AR (CGS21680) agonists 10 min prior to GUO on a GUO-induced anxiolytic-like effect. All the combined treatments blocked the GUO anxiolytic-like effect, whereas when administered alone, each compound was ineffective as compared to the control group. Interestingly, the pretreatment with nonselective antagonist caffeine or selective A1R (DPCPX) or A2AR (ZM241385) antagonists did not modify the GUO-induced anxiolytic-like effect. Finally, binding assay performed in hippocampal membranes showed that [3H]GUO binding became saturable at 100–300 nM, suggesting the existence of a putative GUO binding site. In competition experiments, ADO showed a potency order similar to GUO in displacing [3H]GUO binding, whereas AR selective agonists, CPA and CGS21680, partially displaced [3H]GUO binding, but the sum of the two effects was able to displace [3H]GUO binding to the same extent of ADO alone. Overall, our results strengthen previous data supporting GUO-mediated anxiolytic-like effects, add new evidence that these effects are blocked by A1R and A2AR agonists and pave, although they do not elucidate the mechanism of GUO and ADO receptor interaction, for a better characterization of GUO binding sites in ARs.

27 August 2021 in FASEB BioAdvances
Verified
Journal Article
Open access
PDF file
Vincenzo VerdiVincenzo Verdi
Vincenzo Verdi
ABAnaïs Bécot
Anaïs Bécot
Guillaume Van NielGuillaume Van Niel
Guillaume Van Niel
FVFrederik J. Verweij
Frederik J. Verweij
To harmoniously coordinate the activities of all its different cell types, a multicellular organism critically depends on intercellular communication. One recently discovered mode of intercellular cross‐talk is based on the exchange of "extracellular vesicles" (EVs). EVs are nano‐sized heterogeneous lipid bilayer vesicles enriched in a variety of biomolecules that mediate short‐ and long‐distance communication between different cells, and between cells and their environment. Numerous studies have demonstrated important aspects pertaining to the dynamics of their release, their uptake, and sub‐cellular fate and roles in vitro. However, to demonstrate these and other aspects of EV biology in a relevant, fully physiological context in vivo remains challenging. In this review we analyze the state of the art of EV imaging in vivo, focusing in particular on zebrafish as a promising model to visualize, study, and characterize endogenous EVs in real‐time and expand our understanding of EV biology at cellular and systems level.

7 November 2024 in Oncogene
Verified
Journal Article
Open access
PDF file
CCCheryl Cero
Cheryl Cero
JHJohn S. House
John S. House
Vincenzo VerdiVincenzo Verdi
Vincenzo Verdi
JFJordan L. Ferguson
Jordan L. Ferguson
DJDereje D. Jima
Dereje D. Jima
HSHeather R. Shive
Heather R. Shive
Microenvironmental contributions to soft tissue sarcoma progression are relatively undefined, particularly during sarcoma onset. Use of animal models to reveal these contributions is impeded by difficulties in discriminating between microenvironmental, precancerous, and cancer cells, and challenges in defining a precancerous microenvironment. We developed a zebrafish model that allows segregation of microenvironmental, precancerous, and cancerous cell populations by fluorescence-activated cell sorting. This model has high predilection for malignant peripheral nerve sheath tumor (MPNST), a type of soft tissue sarcoma that exhibits rapid, aggressive growth. Using RNA-seq, we profiled the transcriptomes of microenvironmental, precancerous, and cancer cells from our zebrafish MPNST model. We show broad activation of inflammation/immune-associated signaling networks, describe gene expression patterns that uniquely characterize the transition from precancerous to cancer ME, and identify macrophages as potential contributors to microenvironmental phenotypes. We identify conserved gene expression changes and candidate genes of interest by comparative genomics analysis of MPNST versus benign lesions in both humans and zebrafish. Finally, we functionally validate a candidate extracellular matrix protein, periostin (POSTN), in human MPNST. This work provides insight into how the microenvironment may regulate MPNST initiation and progression.